My HPRA: Register

GAVISCON LIQUID SACHETS

500/267/16 Milligram Oral Suspension

Reckitt Benckiser Ireland LtdPA0979/015/010

Main Information

Trade NameGAVISCON LIQUID SACHETS
Active SubstancesSODIUM ALGINATE
SODIUM BICARBONATE
CALCIUM CARBONATE
Strength500/267/16 Milligram
Dosage FormOral Suspension
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/015/010

Group Information

ATC CodeA02BX13 Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

Status

Authorised/WithdrawnAuthorised
Licence Issued01/10/2010
Supply StatusSupply through general sales
Dispensing StatusProduct not subject to medical prescription
Marketing StatusNot Marketed
Promotion StatusPromotion to the general public
Conditions of LicenceGeneral Sale maximum pack size 30.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.